- Home
- VALU vs HQL Comparison
VALU vs HQL Comparison
Compare VALU & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- HQL
- Stock Information
- Founded
- VALU 1931
- HQL 1992
- Country
- VALU United States
- HQL United States
- Employees
- VALU N/A
- HQL N/A
- Industry
- VALU Investment Managers
- HQL Investment Managers
- Sector
- VALU Finance
- HQL Finance
- Exchange
- VALU Nasdaq
- HQL Nasdaq
- Market Cap
- VALU 345.7M
- HQL 378.8M
- IPO Year
- VALU N/A
- HQL N/A
- Fundamental
- Price
- VALU $37.90
- HQL $13.87
- Analyst Decision
- VALU
- HQL
- Analyst Count
- VALU 0
- HQL 0
- Target Price
- VALU N/A
- HQL N/A
- AVG Volume (30 Days)
- VALU 5.3K
- HQL 120.9K
- Earning Date
- VALU 09-12-2025
- HQL 01-01-0001
- Dividend Yield
- VALU 3.36%
- HQL 11.56%
- EPS Growth
- VALU 8.91
- HQL N/A
- EPS
- VALU 2.20
- HQL 0.79
- Revenue
- VALU $35,079,000.00
- HQL N/A
- Revenue This Year
- VALU N/A
- HQL N/A
- Revenue Next Year
- VALU N/A
- HQL N/A
- P/E Ratio
- VALU $17.66
- HQL $17.08
- Revenue Growth
- VALU N/A
- HQL N/A
- 52 Week Low
- VALU $32.94
- HQL $11.34
- 52 Week High
- VALU $57.68
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- VALU 48.80
- HQL 60.49
- Support Level
- VALU $37.11
- HQL $13.57
- Resistance Level
- VALU $38.85
- HQL $14.10
- Average True Range (ATR)
- VALU 1.03
- HQL 0.19
- MACD
- VALU 0.01
- HQL 0.00
- Stochastic Oscillator
- VALU 58.46
- HQL 78.02
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.